IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.

MLA

Jiang, J., et al. “IRX1 Influences Peritoneal Spreading and Metastasis via Inhibiting BDKRB2-Dependent Neovascularization on Gastric Cancer.” Oncogene, vol. 30, no. 44, Nov. 2011, pp. 4498–508. EBSCOhost, https://doi.org/10.1038/onc.2011.154.

APA

Jiang, J., Liu, W., Guo, X., Zhang, R., Zhi, Q., Ji, J., Zhang, J., Chen, X., Li, J., Zhang, J., Gu, Q., Liu, B., Zhu, Z., & Yu, Y. (2011). IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 30(44), 4498–4508. https://doi.org/10.1038/onc.2011.154

Chicago

Jiang, J, W Liu, X Guo, R Zhang, Q Zhi, J Ji, J Zhang, et al. 2011. “IRX1 Influences Peritoneal Spreading and Metastasis via Inhibiting BDKRB2-Dependent Neovascularization on Gastric Cancer.” Oncogene 30 (44): 4498–4508. doi:10.1038/onc.2011.154.